BiotechTube

Sublingual film containing Dexmedetomidine + Sublingual Placebo Film

Phase 1/2Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Agitation,Psychomotor

Conditions

Agitation,Psychomotor, Dementia

Trial Timeline

Dec 27, 2019 → Jan 24, 2022

NCT ID
NCT04251910

About Sublingual film containing Dexmedetomidine + Sublingual Placebo Film

Sublingual film containing Dexmedetomidine + Sublingual Placebo Film is a phase 1/2 stage product being developed by BioXcel Therapeutics for Agitation,Psychomotor. The current trial status is completed. This product is registered under clinical trial identifier NCT04251910. Target conditions include Agitation,Psychomotor, Dementia.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT04251910Phase 1/2Completed

Competing Products

20 competing products in Agitation,Psychomotor

See all competitors
ProductCompanyStageHype Score
ONO-2020 + PlaceboOno PharmaceuticalPhase 2
52
Quetiapine + Haloperidol + Lorazepam + CogentinAstraZenecaApproved
85
Brexpiprazole, OPC-34712LundbeckPhase 3
74
Brexpiprazole, OPC-34712 + Placebo Oral TabletLundbeckPhase 3
74
BrexpiprazoleLundbeckPhase 3
74
AXS-05 (dextromethorphan-bupropion) + PlaceboAxsome TherapeuticsPhase 3
74
AXS-05 + Bupropion + PlaceboAxsome TherapeuticsPhase 2/3
62
AXS-05 (dextromethorphan-bupropion)Axsome TherapeuticsPhase 3
74
AXS-05 + PlaceboAxsome TherapeuticsPhase 3
74
AXS-05 + PlaceboAxsome TherapeuticsPhase 3
74
Pimavanserin 34 mg + Pimavanserin 20 mgAcadia PharmaceuticalsPhase 2
47
PimavanserinAcadia PharmaceuticalsPhase 2
47
Sublingual film containing Dexmedetomidine (BXCL501) + Placebo FilmBioXcel TherapeuticsPhase 3
69
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
Sublingual film containing BXCL501 (Dexmedetomidine) + Placebo filmBioXcel TherapeuticsPhase 1
25
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
BXCL501 + Matching PlaceboBioXcel TherapeuticsPhase 3
69
Sublingual film containing dexmedetomidine (BXCL501) + Placebo FilmBioXcel TherapeuticsPhase 3
69
BXCL501 + BXCL501 + Placebo filmBioXcel TherapeuticsPhase 2
44
BXCL501 + Placebo filmBioXcel TherapeuticsPhase 2
44

Other Products from BioXcel Therapeutics

Sublingual film containing IgalmiApproved
77
Dexmedetomidine + Lorazepam 2 MG/MLApproved
77
Sublingual film containing Dexmedetomidine (BXCL501) + Placebo FilmPhase 3
69
BXCL501 + Matching PlaceboPhase 3
69
BXCL501 + Matching PlaceboPhase 3
69